TregTherapeuticsChapel Hill, NC, USVaccineest. 2018Chapel Hill, NC, USest. 2018
TregTherapeutics, a preclinical-stage company, develops a novel vaccine for multiple sclerosis treatment, leveraging Treg cells' power to alter autoimmune disease outcomes.
Angel$250k
6
Sonoma BiotherapeuticsSouth San Francisco, CA, USTreg Therapiesest. 2020South San Francisco, CA, USest. 2020
Sonoma Biotherapeutics: Pioneering Treg cell therapies for autoimmune and inflammatory diseases.
Series B$365M146
Autobahn TherapeuticsSan Diego, CA, USRegenerative Medicineest. 2017San Diego, CA, USest. 2017
Autobahn Therapeutics: A regenerative medicine company revitalizing health for CNS disorder patients.
Series C$108.7M25
Tr1xLos Angeles, CA, USCell Therapyest. 2018Los Angeles, CA, USest. 2018
Tr1x: Pioneering cellular therapies for autoimmune disorders, recalibrating the immune system for long-term tolerance.